Crown Bioscience, a global CRO and a JSR Life Sciences company, has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH. The transaction is expected to close in April 2023, subject to customary closing adjustments.   Indivumed GmbH, founded in Germany in 2002, is a global provider of analysis of clinical biospecimens. The transaction will generate two separate Indivumed entities, ‘Indivumed Therapeutics’ and ‘Indivumed Services’. The latter, which is the current...